Menu
Recruiting NCT07738978

Understanding and Enhancing Human Health and Movement

No phase Interventional Spinal Cord Injury Stroke (CVA) or Transient Ischemic Attack Multiple Sclerosis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Neural Prosthesis.
Who it may be relevant to
Registry conditions: Spinal Cord Injury, Stroke (CVA) or Transient Ischemic Attack, Multiple Sclerosis. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

By doing this study, investigators hope to learn how electrical stimulation can improve human movement, biomechanics, and function and to gather information on the safety and effectiveness of an implanted electrical stimulation system after paralysis from spinal cord injury, stroke, multiple sclerosis, and traumatic brain injury.

Detailed description

The purpose of this research study is to better understand how people move, so investigators can develop improved ways to help individuals with lower-limb and/or trunk paralysis perform everyday activities such as sitting, reaching, pushing a wheelchair, transferring, standing, stepping, and maintaining balance.

This study evaluates how activating stabilizing muscles, either with surface electrical stimulation or with an implanted neural stimulation device may change the way these daily activities are performed and potentially enhance functional independence.

A key goal of this project is to collect information on the safety and effectiveness of an implanted neural stimulation system. The U.S. Food and Drug Administration (FDA) permits the limited investigational use of this implanted system for individuals with lower-limb and/or trunk paralysis resulting from neurological conditions.

Interventions

  • Device Neural Prosthesis
    implanted electrical stimulation device

Primary outcome measures

  • Difference in Max Standing Time [Time frame: Study completion - an average of 1 year]
  • Difference in Max Walking distance [Time frame: Study completion - an average of 1 year]

Eligibility criteria

Inclusion criteria

  • Skeletal maturity and ability to sign informed consent (>18 years)
  • Non-ventilator dependent paralysis resulting from injuries such as: mid cervical/thoracic (C4 or below) spinal cord injuries, poststroke hemiparesis, TBI, or MS, affecting the trunk and/or lower limbs
  • Innervated and excitable lower extremity and trunk musculature
  • Adequate social support and stability
  • Willingness to comply with follow-up procedures
  • Time post injury greater than six months
  • Appropriate body habitus (height and weight within acceptable limits as determined by study physician)
  • Neurologically stable as determined by a physician

Exclusion criteria

  • Non-English speaking
  • Females who are pregnant
  • Current pressure injuries that would be exacerbated by study activities
  • Severe contractures or uncontrolled spasticity of any major joint of the upper or lower extremities that results in a fixed deformity that would interfere with study activities
  • History of spontaneous fractures or other evidence of excessively low bone density
  • History of vestibular dysfunction, balance problems, or spontaneous falls
  • Acute and or/untreated orthopedic problems that would prevent a participant from weight bearing or exercising such as a dislocation or fracture.
  • Acute and/or chronic problems left untreated or not controlled that would put a participant at risk by using stimulation such as cardiac abnormalities, immunological/pulmonary/renal/circulatory compromise, diabetes or hypertension
  • Presence of a demand pacemaker or cardiac defibrillator
  • Any other medical or psychological condition that would be a contraindication
  • Current pressure ulcers
  • Significant range of motion limitations that would compromise study activities
  • Body habitus that would compromise study activities

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 1 center
  • Louis Stokes Cleveland VA Medical Center — Cleveland

Identifiers

NCT: NCT07738978 · 1591730

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗